51 related articles for article (PubMed ID: 8615598)
1. In vitro assessment for neurotoxicity of antitumor agents before local administration into central nervous system.
Moriuchi S; Shimizu K; Miyao Y; Yamada M; Ohkawa M; Hayakawa T
Anticancer Res; 1996; 16(1):135-40. PubMed ID: 8615598
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor efficacy of FK 973 on malignant glioma cells].
Shimizu K; Yamada M; Mabuchi E; Matsui Y; Tamura K; Moriuchi S; Park K; Mogami H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2367-72. PubMed ID: 2751317
[TBL] [Abstract][Full Text] [Related]
3. [In vitro chemosensitivity test with several antitumor agents against eight malignant brain tumor cell-lines].
Mabuchi E; Shimizu K; Yamada M; Moriuchi S; Park K; Tamura K; Hayakawa T; Mogami H
Gan To Kagaku Ryoho; 1991 Feb; 18(2):233-8. PubMed ID: 1992917
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse.
Natsume A; Mizuno M; Ryuke Y; Yoshida J
Gene Ther; 1999 Sep; 6(9):1626-33. PubMed ID: 10490773
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of a new antitumor antibiotic, FK973, in malignant glioma.
Moriuchi S; Shimizu K; Yamada M; Mabuchi E; Tamura K; Park KC; Hayakawa T
Anticancer Res; 1991; 11(6):2079-84. PubMed ID: 1776843
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
[TBL] [Abstract][Full Text] [Related]
9. Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.
Nakanishi H; Mizutani Y; Kawauchi A; Ukimura O; Shiraishi T; Hatano M; Mizuno M; Yoshida J; Miki T
Clin Cancer Res; 2003 Mar; 9(3):1129-35. PubMed ID: 12631618
[TBL] [Abstract][Full Text] [Related]
10. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
[TBL] [Abstract][Full Text] [Related]
11. N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
Baker DP; Lin EY; Lin K; Pellegrini M; Petter RC; Chen LL; Arduini RM; Brickelmaier M; Wen D; Hess DM; Chen L; Grant D; Whitty A; Gill A; Lindner DJ; Pepinsky RB
Bioconjug Chem; 2006; 17(1):179-88. PubMed ID: 16417267
[TBL] [Abstract][Full Text] [Related]
12. Interferon beta-mediated vessel stabilization improves delivery and efficacy of systemically administered topotecan in a murine neuroblastoma model.
Dickson PV; Hagedorn NL; Hamner JB; Fraga CH; Ng CY; Stewart CF; Davidoff AM
J Pediatr Surg; 2007 Jan; 42(1):160-5; discussion 165. PubMed ID: 17208558
[TBL] [Abstract][Full Text] [Related]
13. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
Jeremić B; Sibamoto J; Abe M
Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of DNA polymerase beta gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea.
Gomi A; Shinoda S; Sakai R; Hirai H; Ozawa K; Masuzawa T
Biochem Biophys Res Commun; 1996 Oct; 227(2):558-63. PubMed ID: 8878552
[TBL] [Abstract][Full Text] [Related]
15. The effect of interleukin 12 desensitization on the antitumor efficacy of recombinant interleukin 12.
Coughlin CM; Wysocka M; Trinchieri G; Lee WM
Cancer Res; 1997 Jun; 57(12):2460-7. PubMed ID: 9192826
[TBL] [Abstract][Full Text] [Related]
16. Prevention of high-dose-methotrexate neurotoxicity by adequate folinic acid rescue is possible even after central nervous system irradiation.
Cohen IJ
Med Hypotheses; 2007; 68(5):1147-53. PubMed ID: 17270361
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
18. The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro.
Wiranowska M; Tresser N; Saporta S
Anticancer Res; 1998; 18(5A):3331-8. PubMed ID: 9858905
[TBL] [Abstract][Full Text] [Related]
19. Chronopharmacology of antitumor effect induced by interferon-beta in tumor-bearing mice.
Takane H; Ohdo S; Yamada T; Yukawa E; Higuchi S
J Pharmacol Exp Ther; 2000 Aug; 294(2):746-52. PubMed ID: 10900256
[TBL] [Abstract][Full Text] [Related]
20. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
